Casdin Capital as of March 31, 2017
Portfolio Holdings for Casdin Capital
Casdin Capital holds 29 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sage Therapeutics (SAGE) | 10.7 | $18M | 255k | 71.07 | |
| Foundation Medicine | 9.1 | $16M | 480k | 32.25 | |
| Loxo Oncology | 8.9 | $15M | 360k | 42.08 | |
| Agios Pharmaceuticals (AGIO) | 8.2 | $14M | 238k | 58.40 | |
| Blueprint Medicines (BPMC) | 7.0 | $12M | 295k | 39.99 | |
| Evolent Health (EVH) | 6.8 | $12M | 520k | 22.30 | |
| Epizyme | 4.9 | $8.3M | 485k | 17.15 | |
| Spark Therapeutics | 4.2 | $7.2M | 135k | 53.34 | |
| Voyager Therapeutics (VYGR) | 3.9 | $6.6M | 500k | 13.24 | |
| GenMark Diagnostics | 3.0 | $5.1M | 400k | 12.82 | |
| Sangamo Biosciences (SGMO) | 2.6 | $4.4M | 850k | 5.20 | |
| Audentes Therapeutics | 2.6 | $4.4M | 260k | 17.04 | |
| Allscripts Healthcare Solutions (MDRX) | 2.3 | $3.9M | 310k | 12.68 | |
| Global Blood Therapeutics In | 2.2 | $3.7M | 102k | 36.85 | |
| Pacific Biosciences of California (PACB) | 2.1 | $3.6M | 700k | 5.17 | |
| Myokardia | 2.1 | $3.5M | 265k | 13.15 | |
| Kite Pharma | 2.0 | $3.3M | 43k | 78.49 | |
| Codexis (CDXS) | 1.9 | $3.2M | 675k | 4.80 | |
| Amyris | 1.9 | $3.2M | 6.0M | 0.53 | |
| Cytomx Therapeutics (CTMX) | 1.8 | $3.1M | 178k | 17.27 | |
| Editas Medicine (EDIT) | 1.8 | $3.0M | 133k | 22.32 | |
| Syros Pharmaceuticals | 1.7 | $2.9M | 182k | 15.93 | |
| Jounce Therapeutics | 1.7 | $2.9M | 130k | 21.99 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $2.8M | 55k | 51.25 | |
| Tesaro | 1.6 | $2.7M | 18k | 153.89 | |
| Bluebird Bio | 1.4 | $2.3M | 26k | 90.90 | |
| Clovis Oncology | 0.9 | $1.5M | 23k | 63.65 | |
| Adverum Biotechnologies | 0.7 | $1.1M | 420k | 2.70 | |
| Curis | 0.4 | $639k | 230k | 2.78 |
